Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
PLx Pharma Inc. PLXP
$0.09
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
2534980.00000000
-
week52high
3.41
-
week52low
0.01
-
Revenue
8208000
-
P/E TTM
0
-
Beta
3.91967700
-
EPS
-0.39000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 12:30
Описание компании
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Oppenheimer | Perform | Outperform | 15 авг 2022 г. |
| JMP Securities | Market Perform | Market Outperform | 15 авг 2022 г. |
| Raymond James | Outperform | Outperform | 16 мая 2022 г. |
| Raymond James | Outperform | Outperform | 14 мар 2022 г. |
| Raymond James | Outperform | Market Perform | 07 дек 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Giordano Natasha | A | 5186 | 4100 | 15 мар 2022 г. |
| O'Connor Rita M | A | 26670 | 3700 | 15 мар 2022 г. |
| O'Connor Rita M | A | 22970 | 10000 | 15 мар 2022 г. |
| Valentino Michael J | A | 80000 | 80000 | 22 февр 2022 г. |
| O'Connor Rita M | A | 110000 | 110000 | 22 февр 2022 г. |
| HADDEN JOHN | A | 20000 | 20000 | 22 февр 2022 г. |
| Casale Robert | A | 20000 | 20000 | 22 февр 2022 г. |
| Giordano Natasha | A | 300000 | 300000 | 22 февр 2022 г. |
| Balkema Gary S. | A | 20000 | 20000 | 22 февр 2022 г. |
| CALHOUN KIRK K | A | 20000 | 20000 | 22 февр 2022 г. |
Новостная лента
Why Is PLx Pharma (PLXP) Stock Down 32% Today?
InvestorPlace
12 апр 2023 г. в 08:40
PLx Pharma (NASDAQ: PLXP ) stock continues to fall on Wednesday as the company gets closer to being delisted from the Nasdaq Exchange . An update from PLx Pharma revealed that the Nasdaq is not giving it another 180-day period to regain compliance with listing rules.
Why Is PLx Pharma (PLXP) Stock Down 38% Today?
InvestorPlace
11 апр 2023 г. в 09:28
PLx Pharma (NASDAQ: PLXP ) stock is taking a beating on Tuesday and there's a couple of reasons investors will want to know about its fall. First off, traders will keep in mind that PLXP stock underwent a massive rally on Monday.
Spotting Winning Penny Stocks: 3 Top Tips
PennyStocks
11 апр 2023 г. в 06:00
Can these tips help you make money with penny stocks in 2023? The post Spotting Winning Penny Stocks: 3 Top Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PLx Pharma (PLXP) Q3 2022 Earnings Call Transcript
Seeking Alpha
11 ноя 2022 г. в 11:13
PLx Pharma Inc. (NASDAQ:PLXP ) Q3 2022 Earnings Conference Call November 11, 2022 8:30 AM ET Company Participants Natasha Giordano - President, Chief Executive Officer Rita O'Connor - Chief Financial Officer Asif Ali - Preventative Cardiologist Janet Barth - Vice President, Investor Relations Conference Call Participants Leland Gershell - Oppenheimer Jason Butler - JMP Securities Operator Ladies and gentlemen, thank you for standing by and welcome to PLx Pharma's third quarter 2022 earnings conference call. At this time, all participants are in a listen-only mode.
PLx Pharma, Inc. (PLXP) Reports Q3 Loss, Misses Revenue Estimates
Zacks Investment Research
10 ноя 2022 г. в 19:33
PLx Pharma, Inc. (PLXP) delivered earnings and revenue surprises of 15.91% and 35.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?